Categories: Health

US Approves Drug To Improve Growth In Children With Dwarfism

In this file photo taken on July 20, 2020, a sign for the Food And Drug Administration is seen outside of the headquarters in White Oak, Maryland. (Photo by Sarah Silbiger / GETTY IMAGES NORTH AMERICA / AFP)

 

The US Food and Drug Administration on Friday approved for the first time a drug to improve growth in children with the most common type of dwarfism. 

Voxzogo, manufactured by American pharmaceutical company BioMarin, is authorized in the US to treat kids older than five with achondroplasia whose growth plates — zones of cartilage at the end of long bones — are still open, meaning they still have the potential to grow.

“With this action, children with short stature due to achondroplasia have a treatment option that targets the underlying cause of their short stature,” said FDA endocrinologist Theresa Kehoe in a press release.

Achondroplasia is a genetic bone growth disorder that blocks the changing of cartilage to bone. Adults with the condition grow to be about four feet tall (1.2 meters) on average.

It can cause health issues including breathing problems, exaggerated spine curvature, obesity, and recurrent ear infections, according to the National Institutes of Health. Life span is usually near normal.

“As a parent of a child with achondroplasia, I see the availability of treatments that impact bone growth as an important step forward,” Amer Haider, the co-founder of nonprofit group Growing Stronger, said in the BioMarin statement.

Growing Stronger is dedicated to improving the quality of medical care for little people through supporting research.

But growing taller is not necessarily the goal of all with achondroplasia.

When BioMarin shared preliminary test results in 2015, dwarfism advocacy organization Little People of America (LPA) emphasized that it aims to celebrate dwarfism as a “valuable contribution to the diversity of the human condition.”

“While we encourage individuals and families to make the decision that is best for them, we stress that emerging treatments are not necessary for people with dwarfism to live engaging, healthy, productive lives,” the LPA statement said.


RELATED

US Cars Mandated To Spot Drunk Drivers And Stop Them

US Wants To Produce One Billion Doses Of mRNA Vaccines Yearly


 

 Year-long study 

The safety and efficacy of Voxzogo, or vosoritide, was evaluated in a year-long, double-blind study for participants five years and older with achondroplasia who have open epiphyses, or growth plates, the FDA said.

Kids who received a Voxzogo injection grew on average about 0.6 inches (1.57 centimeters) taller than those who received a placebo over the period of study.

People with achondroplasia have a genetic mutation that causes a growth regulation gene to be overactive, preventing normal bone growth. Voxzogo works by counteracting the mutation.

The most common side effects were injection site reactions, vomiting, and potentially serious decreased blood pressure.

The European Commission authorized the drug to treat still-growing children older than two years in late August this year.

The medicine is expected to be available in the United States by mid-to-late- December, according to BioMarin.

AFP

Emmanuel Egobiambu

Disqus Comments Loading...
Share
Published by
Emmanuel Egobiambu
Tags: Drug dwarfism us

Recent Posts

  • Local

Benue Govt Raises Fine For Impounded Animals From N2,000 To N50,000

  The Benue State government has raised the fine for impounded animals from N2,000 to N50,000, with an additional N20,000…

1 hour ago
  • Sports

Jota Double Fires Liverpool Into League Cup Final

  Diogo Jota fired Liverpool into the League Cup final against Chelsea as the Portugal forward's double sealed a 2-0…

1 hour ago
  • Sports

Nigeria To Play Tunisia In AFCON Second Round

  Nigeria is set to play Tunisia on Sunday in the second round of the Africa Cup of Nations being…

2 hours ago
  • Africa

Many Feared Dead In Ghana As Explosives Truck, Motorcycle Crash

  A truck carrying explosives collided with a motorcyle in western Ghana on Thursday, causing an immense conflagration and the…

2 hours ago
  • Politics

2023 Elections: All PVCs Issued Are Valid And Subsisting – INEC

The Independent National Electoral Commission (INEC) has dismissed claims that the Permanent Voters Cards (PVCs) issued to Nigerian voters are…

2 hours ago
  • World News

China, Russia Block US Push For UN Sanctions On N. Koreans: Diplomats

  China and Russia on Thursday blocked a US push to impose United Nations sanctions on five North Koreans in…

3 hours ago